Filter
2226
Filtered Results: 2226
Text search:
drug
interactions
Featured
Recommendations
216
New Publications
543
Language
Document type
No document type
1442
Studies & Reports
275
Guidelines
275
Manuals
100
Strategic & Response Plan
50
Training Material
40
Fact sheets
31
Situation Updates
9
Resource Platforms
2
Infographics
2
Countries / Regions
India
128
Kenya
71
Global
70
South Africa
61
Ethiopia
49
Western and Central Europe
48
Nigeria
44
Nepal
43
Uganda
42
Tanzania
39
Sierra Leone
35
Malawi
35
Liberia
33
Latin America and the Carribbean
29
Zambia
29
Africa
28
Ghana
27
Bangladesh
26
Ukraine
23
Myanmar / Burma
22
Rwanda
21
Namibia
21
Eastern Europe
19
Cambodia
16
Russia
16
Lesotho
15
Philippines
15
Botswana
15
South–East Asia Region
14
Zimbabwe
11
Asia
11
Congo, Democratic Republic of
11
Eswatini/ Swaziland
9
Syria
8
Mozambique
8
USA
8
West and Central Africa
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
Indonesia
7
Germany
6
Tajikistan
5
East and Southern Africa
5
Brazil
5
South Sudan
5
Thailand
4
Afghanistan
4
Haiti
4
Georgia
4
Pakistan
4
Chile
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Guinea
3
Western Pacific Region
3
United Kingdom
3
Vietnam
3
North Macedonia
2
Colombia
2
Kazakhstan
2
Senegal
2
Kyrgyzstan
2
Peru
2
Armenia
2
North America
2
Southern Africa
2
Argentina
2
Sri Lanka
2
Sudan
2
Yemen
2
Iraq
2
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Turkey
1
Benin
1
Gambia
1
China
1
Iran
1
Canada
1
Estonia
1
Austria
1
Qatar
1
Venezuela
1
Ireland
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Spain
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Palestine
1
Libya
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
765
Clinical Guidelines
237
Public Health
132
Women & Child Health
71
Capacity Building
48
Key Resources
35
Pharmacy & Technologies
11
Toolboxes
Mental Health
326
HIV
260
TB
227
COVID-19
97
AMR
87
Pharmacy
62
NTDs
59
NCDs
50
Caregiver
44
Disability
39
Planetary Health
38
Ebola
32
Global Health Education
30
Rapid Response
28
Refugee
20
Conflict
13
Polio
10
Specific Hazards
8
Social Ethics
8
Health Financing Toolbox
6
Natural Hazards
5
Cholera
5
Zika
2
BMJ Open Science 2021;5:e100202. doi:10.1136/
bmjos-2021-100202
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra...
This companion document to Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030 ("the road map") aims to support a range of stakeholders - including countries in which neglected tropical diseases (NTDs) are endemic, international organi...
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment ...
Environmental pollution, protection, quality and sustainability
The Region of the Americas comprises 46 countries and territories and Brazil and Peru are among the WHO high- TB burden
countries. T o illustrate the recent increase in TB incidence in the region, we selected 12 countries from Latin America (Argentina,
Brazil, Chile, Colombia, Ecuador, El Salvador...
Health Policy and Planning, Volume 35, Issue 1, February 2020, Pages 47–57, https://doi.org/10.1093/heapol/czz122
Colombia has an underreporting of 30% of the total cases, according to World Health Organization (WHO) estimations. In 2016, successful tuberculosis (TB) treatment rate was 70%, and t...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
From February 22-23, 2023, the Wellcome Trust and the Global Task Force on Cholera Control (GTFCC) brought together researchers, decision makers, and public health implementers to participate in a virtual workshop focused on cholera and climate. Day 1 involved a technical workshop to identify key re...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
